3Analytics
3Analytics is an AI-driven company founded in January 2020 in Silicon Valley, CA, dedicated to improving the safety of drugs, vaccines, medical devices, and cosmetics. Leveraging cutting-edge artificial intelligence, machine learning, and natural language processing, their GxP-compliant platform offers advanced solutions for literature surveillance, signal management, IMDRF coding, and complaint processing. The company's mission is to revolutionize safety analytics by empowering organizations with data-driven decisions and proactive risk management. Their solutions, including Signals, BioMed Literature, and RegIntel, are designed to optimize compliance, streamline workflows, and provide actionable insights, ensuring global regulatory adherence and enhancing patient safety. They have partnered with organizations like JHPIEGO and been shortlisted by the WHO.
3Analytics
3Analytics is an AI-driven company founded in January 2020 in Silicon Valley, CA, dedicated to improving the safety of drugs, vaccines, medical devices, and cosmetics. Leveraging cutting-edge artificial intelligence, machine learning, and natural language processing, their GxP-compliant platform offers advanced solutions for literature surveillance, signal management, IMDRF coding, and complaint processing. The company's mission is to revolutionize safety analytics by empowering organizations with data-driven decisions and proactive risk management. Their solutions, including Signals, BioMed Literature, and RegIntel, are designed to optimize compliance, streamline workflows, and provide actionable insights, ensuring global regulatory adherence and enhancing patient safety. They have partnered with organizations like JHPIEGO and been shortlisted by the WHO.
